Abstract

We analyze the possible predictive variables for Adverse Events (AEs) during sedation for gastrointestinal (GI) endoscopy. We consider 23,788 GI endoscopies under sedation on adults between 2012 and 2019. A Zero-Inflated Poisson Regression Mixture (ZIPRM) model for count data with concomitant variables is applied, accounting for unobserved heterogeneity and evaluating the risks of multi-drug sedation. A multinomial logit model is also estimated to evaluate cardiovascular, respiratory, hemorrhagic, other AEs and stopping the procedure risk factors. In 7.55% of cases, one or more AEs occurred, most frequently cardiovascular (3.26%) or respiratory (2.77%). Our ZIPRM model identifies one population for non-zero counts. The AE-group reveals that age >75 years yields 46% more AEs than age <66 years; Body Mass Index (BMI) ≥27 27% more AEs than BMI <21; emergency 11% more AEs than routine. Any one-point increment in the American Society of Anesthesiologists (ASA) score and the Mallampati score determines respectively a 42% and a 16% increment in AEs; every hour prolonging endoscopy increases AEs by 41%. Regarding sedation with propofol alone (the sedative of choice), adding opioids to propofol increases AEs by 43% and adding benzodiazepines by 51%. Cardiovascular AEs are increased by age, ASA score, smoke, in-hospital, procedure duration, midazolam/fentanyl associated with propofol. Respiratory AEs are increased by BMI, ASA and Mallampati scores, emergency, in-hospital, procedure duration, midazolam/fentanyl associated with propofol. Hemorrhagic AEs are increased by age, in-hospital, procedure duration, midazolam/fentanyl associated with propofol. The risk of suspension of the endoscopic procedure before accomplishment is increased by female gender, ASA and Mallampati scores, and in-hospital, and it is reduced by emergency and procedure duration. Age, BMI, ASA score, Mallampati score, in-hospital, procedure duration, other sedatives with propofol increase the risk for AEs during sedation for GI endoscopy.

Highlights

  • Sedation is often needed to improve the tolerability of gastrointestinal (GI) endoscopy procedures

  • Cardiovascular adverse events (AEs) are increased by age, American Society of Anesthesiologists (ASA) score, smoke, in-hospital, procedure duration, midazolam/fentanyl associated with propofol

  • Respiratory AEs are increased by Body Mass Index (BMI), ASA and Mallampati scores, emergency, in-hospital, procedure duration, midazolam/fentanyl associated with propofol

Read more

Summary

Introduction

Sedation is often needed to improve the tolerability of gastrointestinal (GI) endoscopy procedures. In this setting, a crucial issue is to identify predictive factors for sedation-related adverse events (AEs) [1,2,3]. Besides adding to anesthesiological knowledge, this interest stems from the current debate about possible non-anesthesiologist-delivered sedation in GI. The population of patients undergoing GI endoscopy changes over time, and endoscopic procedures are more often performed on older and more compromised patients [5], especially in countries suffering from demographic declines, like Italy. We analyze the possible predictive variables for Adverse Events (AEs) during sedation for gastrointestinal (GI) endoscopy

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call